RBC transfusion

Related by string. RBC transfusions * RBCs . RBCS . Rbc : RBC Capital Markets . RBC #.#.# Moscow . RBC Dominion Securities . RBC Wealth Management . RBC #.#.# Kiev . RBC Capital Mkts / transfusions . Transfusions . Transfusion : blood transfusions organ transplants . transfusion dependent . tainted blood transfusions . tainted blood transfusion . necessitate blood transfusion * *

Related by context. Frequent words. (Click for all words.) 62 HSCT 62 lymphopenia 62 hemoglobin concentration 59 leukopenia 59 azacitidine 58 febrile neutropenia 58 glycated hemoglobin 57 confidence interval CI 57 P = .# 57 haematological 57 % CI #.#-#.# [006] 56 left ventricular systolic 56 distant metastasis 56 serum uric acid 56 hematologic 56 LVEF 56 HbA 1c 56 HbA1c levels 56 laboratory abnormalities 56 chemoradiotherapy 56 Secondary endpoints include 56 confidence interval #.#-#.# 56 alkaline phosphatase 56 serum sodium 56 56 mg kg dose 55 nM 55 Secondary endpoints included 55 cytogenetic response 55 thrombocytopenia 55 CI -#.# 55 coronary revascularization 55 CMV infection 55 CI #.#-#.# [002] 55 T2DM 55 cardiac dysfunction 55 fibrinolysis 55 NYHA class 55 pg mL 54 achieved statistical significance 54 prognostic factor 54 reoperation 54 nmol L 54 patients evaluable 54 neoadjuvant chemotherapy 54 tumor resection 54 VIDAZA 54 statistically significant p = 54 myelodysplastic syndromes MDS 54 n = 54 evaluable 54 epoetin alfa 54 thromboembolic events 54 serum phosphorus 54 VUR 54 plus methotrexate 54 nephrectomy 54 grade gliomas 54 cerebrovascular events 54 complete remissions 54 Neutropenia 53 MetS 53 irbesartan 53 glycemia 53 romiplostim 53 histologically 53 serum concentrations 53 SHPT 53 ventilatory 53 hypokalemia 53 neoadjuvant therapy 53 allogeneic stem cell 53 mg BID 53 RECIST criteria 53 thrombolytic therapy 53 tumor recurrence 53 epithelial ovarian cancer 53 lipid lowering therapy 53 CD4 + cell 53 systemic embolism 53 metastatic renal cell carcinoma 53 pg ml 53 neoadjuvant 53 androgen deprivation 53 lymph node involvement 53 DOXIL 53 nonsignificant 53 cystectomy 53 mRNA expression 53 allogeneic 52 μg kg 52 hemolysis 52 distant metastases 52 virologic failure 52 EBRT 52 g dL 52 mediated immunity 52 Lenalidomide 52 Secondary endpoints 52 breast carcinoma 52 Arch Intern Med

Back to home page